These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database. Saccardi R; Kozak T; Bocelli-Tyndall C; Fassas A; Kazis A; Havrdova E; Carreras E; Saiz A; Löwenberg B; te Boekhorst PA; Gualandio F; Openshaw H; Longo G; Pagliai F; Massacesi L; Deconink E; Ouyang J; Nagore FJ; Besalduch J; Lisukov IA; Bonini A; Merelli E; Slavino S; Gratwohl A; Passweg J; Tyndall A; Steck AJ; Andolina M; Capobianco M; Martin JL; Lugaresi A; Meucci G; Sáez RA; Clark RE; Fernandez MN; Fouillard L; Herstenstein B; Koza V; Cocco E; Baurmann H; Mancardi GL; Mult Scler; 2006 Dec; 12(6):814-23. PubMed ID: 17263012 [TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes of autologous hematopoietic stem cell transplantation with reduced-intensity conditioning in multiple sclerosis: physician's and patient's perspectives. Shevchenko JL; Kuznetsov AN; Ionova TI; Melnichenko VY; Fedorenko DA; Kurbatova KA; Gorodokin GI; Novik AA Ann Hematol; 2015 Jul; 94(7):1149-57. PubMed ID: 25711670 [TBL] [Abstract][Full Text] [Related]
7. Clinical outcome of autologous peripheral blood stem cell transplantation in opticospinal and conventional forms of secondary progressive multiple sclerosis in a Chinese population. Xu J; Ji BX; Su L; Dong HQ; Sun WL; Wan SG; Liu YO; Zhang P; Liu CY Ann Hematol; 2011 Mar; 90(3):343-8. PubMed ID: 20872003 [TBL] [Abstract][Full Text] [Related]
8. Autologous hematopoietic stem cell transplantation in combination with immunoablative protocol in secondary progressive multiple sclerosis--A 10-year follow-up of the first transplanted patient. Obradović D; Tukić L; Radovinović-Tasić S; Petrović B; Elez M; Ostojić G; Balint B Vojnosanit Pregl; 2016 May; 73(5):504-8. PubMed ID: 27430119 [TBL] [Abstract][Full Text] [Related]
9. Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience. Burman J; Iacobaeus E; Svenningsson A; Lycke J; Gunnarsson M; Nilsson P; Vrethem M; Fredrikson S; Martin C; Sandstedt A; Uggla B; Lenhoff S; Johansson JE; Isaksson C; Hägglund H; Carlson K; Fagius J J Neurol Neurosurg Psychiatry; 2014 Oct; 85(10):1116-21. PubMed ID: 24554104 [TBL] [Abstract][Full Text] [Related]
10. Low intensity lympho-ablative regimen followed by autologous hematopoietic stem cell transplantation in severe forms of multiple sclerosis: A MRI-based clinical study. Curro' D; Vuolo L; Gualandi F; Bacigalupo A; Roccatagliata L; Capello E; Uccelli A; Saccardi R; Sormani MP; Mancardi G Mult Scler; 2015 Oct; 21(11):1423-30. PubMed ID: 25583838 [TBL] [Abstract][Full Text] [Related]
11. Association of nonmyeloablative hematopoietic stem cell transplantation with neurological disability in patients with relapsing-remitting multiple sclerosis. Burt RK; Balabanov R; Han X; Sharrack B; Morgan A; Quigley K; Yaung K; Helenowski IB; Jovanovic B; Spahovic D; Arnautovic I; Lee DC; Benefield BC; Futterer S; Oliveira MC; Burman J JAMA; 2015 Jan; 313(3):275-84. PubMed ID: 25602998 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of autologous hematopoietic stem-cell transplantation in multiple sclerosis: a systematic review and meta-analysis. Ge F; Lin H; Li Z; Chang T Neurol Sci; 2019 Mar; 40(3):479-487. PubMed ID: 30535563 [TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up more than 10 years after HSCT: a monocentric experience. Frau J; Carai M; Coghe G; Fenu G; Lorefice L; La Nasa G; Mamusa E; Vacca A; Marrosu MG; Cocco E J Neurol; 2018 Feb; 265(2):410-416. PubMed ID: 29270686 [TBL] [Abstract][Full Text] [Related]